PATENT CLAIM ANALYSIS

Application Number: 16047424
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "471000"]

Abstract:
The present invention provides for novel formulations of clopidogrel in combination ton pump inhibitors (PPI), optionally with NSAIDs, for use as improved antiplatelet therapies in stroke and cardiovascular indications.

Claim (Index 65):
A method of treating a subject with an antiplatelet therapy comprising administering to said subject:\n (a) enteric-coated aspirin coformulated with immediate-release omeprazole; and (b) clopidogrel, wherein (a) and (b) are dosed at least 10 hours apart.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.09677
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13411701', '14940064', '12254640', '11696554', '10641732']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7071377169766554
- 35 USC 102 Novelty (BERT): 0.49243488647224
- Combined Prediction Score: 0.6856674339262139
- Mean Citation Score: 189.15951
- Max Citation Score: 204.19553
- Similarity Product: 136.8738108783573

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test